| Active ingredient (INN) | Rifabutin |
|---|---|
| Brand names | MYCOBUTIN Rifabutin |
| Therapeutic category | Auto-created by Therapeutic Goods Administration — Medicine Shortages scraper |
| Controlled substance | No |
| Marketing-authorisation holders | Pfizer Australia Pty Ltd, Marlex Pharmaceuticals, Inc. |
| Registrations on file | 2 |
| Patient information leaflet (PIL) | Not on file |
| Summary of product characteristics (SPC) | Not on file |
| Product | Strength | Form | Market | MA holder | Status |
|---|---|---|---|---|---|
| MYCOBUTIN Rifabutin | 150mg | — | 🇦🇺 AU | Pfizer Australia Pty Ltd | Active |
| Rifabutin | 150mg/1 | capsule | 🇺🇸 US | Marlex Pharmaceuticals, Inc. | Active |